S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
Nigeria's central bank chief arrested after being suspended by president
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Boris Johnson's bombshell exit from Parliament leaves UK politics reeling
Can a chatbot preach a good sermon? Hundreds attend church service generated by ChatGPT to find out
OTCMKTS:MLXSF

Melexis (MLXSF) Stock Forecast, Price & News

$73.20
0.00 (0.00%)
(As of 05/12/2023)
Compare
Today's Range
$73.20
$73.20
50-Day Range
$73.20
$73.20
52-Week Range
$73.20
$73.20
Volume
N/A
Average Volume
150 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$82.50

MLXSF stock logo

About Melexis (OTCMKTS:MLXSF) Stock

Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN/CAN system basis, NFC/RFID, radio-frequency receiver and transmitter, and switch controller ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.

Receive MLXSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Melexis and its competitors with MarketBeat's FREE daily newsletter.

MLXSF Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Melexis NV (MLXSF)
Melexis Stock (OTC:MLXSF), Dividends
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert
Now, after years of big gains, he says one popular company's day in the sun is finally coming to an end. You must get off this sinking ship – NOW. 1 million people follow him for his surprisingly accurate predictions. His new sell alert could save your wealth in 2023.
Four clues to the quality of Melexis NV (EBR:MELE)
See More Headlines

MLXSF Price History

Industry, Sector and Symbol

Industry
Semiconductors
Sub-Industry
N/A
Current Symbol
OTCMKTS:MLXSF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
1,539
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$82.50
High Stock Price Forecast
$90.00
Low Stock Price Forecast
$75.00
Forecasted Upside/Downside
+12.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Marc Biron (Age 52)
    MD, CEO & Director
    Comp: $772.67k
  • Ms. Karen Van Griensven (Age 52)
    Chief Financial Officer
  • Ms. Veerle Lozie (Age 48)
    Chief Operations & Information Officer
  • Geert Reynders
    Head of IR
  • Ms. Heidi Stieglitz (Age 62)
    VP of HR & Sites













MLXSF Stock - Frequently Asked Questions

Should I buy or sell Melexis stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Melexis in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MLXSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MLXSF, but not buy additional shares or sell existing shares.
View MLXSF analyst ratings
or view top-rated stocks.

What is Melexis' stock price forecast for 2023?

2 equities research analysts have issued 12 month target prices for Melexis' stock. Their MLXSF share price forecasts range from $75.00 to $90.00. On average, they anticipate the company's stock price to reach $82.50 in the next year. This suggests a possible upside of 12.7% from the stock's current price.
View analysts price targets for MLXSF
or view top-rated stocks among Wall Street analysts.

How have MLXSF shares performed in 2023?

Melexis' stock was trading at $73.1950 at the beginning of 2023. Since then, MLXSF shares have increased by 0.0% and is now trading at $73.1950.
View the best growth stocks for 2023 here
.

Are investors shorting Melexis?

Melexis saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 43,200 shares, a decline of 16.1% from the April 30th total of 51,500 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
View Melexis' Short Interest
.

What is Melexis' stock symbol?

Melexis trades on the OTCMKTS under the ticker symbol "MLXSF."

How do I buy shares of Melexis?

Shares of MLXSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Melexis' stock price today?

One share of MLXSF stock can currently be purchased for approximately $73.20.

How many employees does Melexis have?

The company employs 1,539 workers across the globe.

This page (OTCMKTS:MLXSF) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -